Controversies in Pancreatic Cancer Surveillance Guidelines & Role of Blood-Based Biomarker Testing

Dr. Raymond Wadlow, an oncologist at Inova Schar Cancer Institute, provides an overview of the evolving role of blood-based biomarker testing in the early detection of pancreatic cancer, situating it within the current pancreatic cancer landscape. He discusses ongoing challenges in surveillance, particularly for individuals at increased risk, and highlights how blood-based biomarkers can complement existing screening approaches, along with a review of current guidelines for high-risk populations. Speaker: Raymond Wadlow, MD Director, Inova Saville Pancreatic Cancer Screening and Early Detection Clinic; Co-Director, Gastrointestinal Oncology, Inova Schar Cancer Institute Thank you to Immunovia for sponsoring this webinar.